Imunon Inc
For the period ended Dec 31, 2024. Filed Feb 27, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 27, 2025
IMNN$0.88+4.5%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Comprehensive Loss
| Years Ended December 31, | |||
|---|---|---|---|
| 2024 · 2023 | |||
| Other comprehensive loss | |||
| Changes in: | |||
| Realized and unrealized gains on available for sale securities, net | $ | - | $34,302 |
| Net loss | (18,620,242) | (19,514,977) | |
| Total comprehensive loss | $(18,620,242) | $(19,480,675) | |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.